Auteurs
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur la COVID en France - Analysis (France)

Index « Auteurs » - entrée « M. Blatzer »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
M. Ballester < M. Blatzer < M. Bossert  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
000027 (2020) M. Plaze [France] ; D. Attali [France] ; A-C Petit [France] ; M. Blatzer [France] ; E. Simon-Loriere [France] ; F. Vinckier [France] ; A. Cachia [France] ; F. Chrétien [France] ; R. Gaillard [France][Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
000091 (2020) M. Plaze [France] ; D. Attali [France] ; A-C Petit [France] ; M. Blatzer [France] ; E. Simon-Loriere [France] ; F. Vinckier [France] ; A. Cachia [France] ; F. Chrétien [France] ; R. Gaillard [France]Repurposing chlorpromazine to treat COVID-19: The reCoVery study.

List of associated KwdEn.i

Nombre de
documents		Descripteur
2Antiviral Agents (therapeutic use)
2Chlorpromazine (therapeutic use)
2Coronavirus Infections (drug therapy)
2Coronavirus Infections (epidemiology)
2Drug Repositioning (MeSH)
2Endocytosis (drug effects)
2France (epidemiology)
2Humans (MeSH)
2Pandemics (MeSH)
2Pilot Projects (MeSH)
2Pneumonia, Viral (drug therapy)
2Pneumonia, Viral (epidemiology)
2Single-Blind Method (MeSH)
1Antiviral Agents (pharmacokinetics)
1Antiviral Agents (pharmacology)
1Anxiety (complications)
1Anxiety (drug therapy)
1Anxiety (epidemiology)
1Anxiety (pathology)
1Betacoronavirus (MeSH)
1Betacoronavirus (pathogenicity)
1Biomarkers (MeSH)
1Blood-Brain Barrier (MeSH)
1Blood-Brain Barrier (drug effects)
1Chlorpromazine (pharmacokinetics)
1Chlorpromazine (pharmacology)
1Clathrin-Coated Vesicles (drug effects)
1Clinical Trials, Phase III as Topic (methods)
1Coronavirus Infections (complications)
1Coronavirus Infections (immunology)
1Coronavirus Infections (pathology)
1Cytokines (blood)
1Disease Progression (MeSH)
1Dose-Response Relationship, Drug (MeSH)
1Dyspnea (drug therapy)
1Dyspnea (epidemiology)
1Dyspnea (pathology)
1Dyspnea (psychology)
1Length of Stay (MeSH)
1Lung (metabolism)
1Mental Disorders (drug therapy)
1Mental Disorders (epidemiology)
1Mortality (MeSH)
1Multicenter Studies as Topic (methods)
1Patient Outcome Assessment (MeSH)
1Patient Selection (MeSH)
1Pneumonia, Viral (complications)
1Pneumonia, Viral (immunology)
1Pneumonia, Viral (pathology)
1Randomized Controlled Trials as Topic (methods)
1Recovery of Function (MeSH)
1Research Design (MeSH)
1Saliva (metabolism)
1Severity of Illness Index (MeSH)
1Time-to-Treatment (MeSH)
1Tissue Distribution (MeSH)
1Treatment Outcome (MeSH)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "M. Blatzer" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "M. Blatzer" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    M. Blatzer
}}
Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021